Extracorporeal Circulation
15
2
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
27%
4 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (15)
Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)
Central and Peripheral Arterial Pressure Decoupling In Cardio-Pulmonary Bypass
Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : Pilot Study in Adult Elective Conventional Cardiac Surgery
Biocompatible Versus Non-coated Extracorporeal Circuits in Cardiac Surgery
Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery
Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome
Interchangeability of Arterial Coagulation and Venous Coagulation, in the Context of Cardiac Surgeries Under Cardiopulmonary Bypass, Using the DMDiv Hemochron Signature Elite
Anticoagulation Management in Complex Cardiac Surgery
Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation
Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)
Removal of Cytokines in Patients Undergoing Cardiac Surgery With CPB
Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery
Cerebral Embolic Load in Patients Undergoing Surgical Aortic Valve Replacement: A Comparison of the Conventional With the Minimized Extracorporeal Circulation Technique Using Transcranial Doppler Ultrasound
RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.
Coronary Bypass and Artotic Leaflet Surgery : Heparin Low Dose vs Full Dose